Download TGS TA HSV 1 IgG
Transcript
TGS TA HSV 1 IgG Sample 1 2 3 REF Reagents Lot no. 2 3 2 3 2 3 Average concentration (UA/mL) 32.6 36.3 122.1 119.2 225.5 229.2 YB500028 SD CV % 1.63 1.17 6.13 5.31 13.00 14.97 5.0 3.2 5.0 4.5 5.8 6.5 The reproducibility was calculated by analysing the results of the determination of four sera (one negative and three positive with differing concentrations of anti-HSV 1 IgG) performed in single replicate, in 16 different sessions, with two lots of reagents. The concentration of the negative anti-HSV 1 IgG (H1G-N6) serum gave results in the range from 0.4 to 1.0 UA/mL. The table shows the results obtained with the 3 positive sera. Sample Average concentration (UA/mL) SD (UA/mL) CV % 1 70.8 5.87 8.3 2 118.0 7.96 6.7 3 215.7 13.39 6.2 Linearity of the Dilutions The linearity of the TGS TA HSV 1 IgG kit was assessed using a protocol based on the guidelines given in Clinical and Laboratory Standards (CLSI) document EP6-A. Serial dilutions, performed by using the System Liquid, of 3 sera with high concentrations of anti-HSV 1 IgG were dosed. The results of this study are summed up in the table below. IFU038TGS TA – Version: 02 – 15 September 2014 Page 11 di 14